Skip to content

Evaluation of efficacy, acceptability and safety of two different solutions of PEG for colonoscopy in children: a prospective randomized trial. - Different PEG solutions for colonoscopy in children

Evaluation of efficacy, acceptability and safety of two different solutions of PEG for colonoscopy in children: a prospective randomized trial. - Different PEG solutions for colonoscopy in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-003244-11-IT
Enrollment
Unknown
Registered
2009-03-30
Start date
2007-02-27
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children undergoing colonoscopy. MedDRA version: 9.1 Level: LLT Classification code 10010011 Term: Colonoscopy normal

Interventions

Trade Name: ISOCOLAN Pharmaceutical Form: Powder for oral solution INN or Proposed INN: SODIO SOLFATO ANIDRO CAS Number: 7757-82-6 Concentration unit: g/l gram(s)/litre Concentration type: equal Conce

Sponsors

ISTITUTO PER L`INFANZIA BURLO GAROFOLO
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Day- Hospital or admitted children (3-20 years old) undergoing colonoscopy. Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Children undergoing emergency colonoscopy

Design outcomes

Primary

MeasureTime frame
Main Objective: To compare two dfferent PEG solutions, with and without salts, in the same concentration and equal volumes, for intestinal cleanup for colonoscopy in children (3-20 yrs).;Secondary Objective: not defined;Primary end point(s): - Efficacy in intestinal cleasing - Tollerability of solutions, noting possible adverse events, such as sickness, vomiting, abdominal pain, sleeplessness -Therapy compliance -Safety

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026